latest news in www.globenewswire.com
Evolv Technologies Faces Legal Challenge Over Financial Reporting
New York, Wednesday, 13 November 2024.
Evolv Technologies Holdings, Inc. is confronting a securities class action lawsuit filed by Levi & Korsinsky, LLP. The suit alleges misleading financial statements and improper revenue recognition between August 2022 and October 2024. Investors have until December 31, 2024, to seek lead plaintiff status.
Tartaric Acid Industry Expands into Agriculture and Pharmaceuticals
Delhi, Wednesday, 13 November 2024.
India’s tartaric acid market is poised for growth, with new applications emerging in agriculture and pharmaceuticals. The industry, projected to reach $28.53 million by 2030, is seeing increased demand in food processing and cosmetics sectors. Potassium tartrate dominates the market, while West India leads in production due to its proximity to sugarcane fields.
AI Revolution in Military Communications: Enhancing Security and Efficiency
New York, Wednesday, 13 November 2024.
The military communication sector is undergoing a significant transformation, driven by AI integration, satellite technology advancements, and a shift towards software-defined networking. These innovations are set to bolster cybersecurity and operational resilience in global military communications, with the market projected to reach $49.19 billion by 2029.
Canada Prepares for Groundbreaking Health Summit
Canada, Wednesday, 13 November 2024.
Canada’s first Precision Health and Longevity Summit, set for November 15-16, 2024, in Calgary, aims to establish the nation as a leader in health optimization. The event will unite global experts to discuss AI-driven healthcare, personalized medicine, and innovative longevity strategies.
Biodegradable Packaging Market Set to Soar to $800 Billion by 2032
New York, Wednesday, 13 November 2024.
The global biodegradable packaging market is projected to reach $800.48 billion by 2032, growing at a 6.0% CAGR. This surge is driven by increasing environmental awareness and evolving consumer preferences for sustainable solutions. The Asia Pacific region currently holds the largest market share, while North America is expected to experience the fastest growth rate in the coming years.
China's PV Market Set for Explosive Growth, Driven by Tech Giants
Beijing, Wednesday, 13 November 2024.
China’s physical vapor deposition market is projected to reach $1.1 billion by 2030, growing at 8.4% annually from 2025. This surge, led by companies like Advanced Energy Industries and Applied Materials, is fueled by increasing demand in medical equipment, solar products, and data storage sectors.
Copper Demand Skyrockets: 300% Growth in 50 Years
Dublin, Wednesday, 13 November 2024.
Global copper usage has surged 300% over five decades, reaching 26.5 million tons in 2023. This unprecedented growth, driven by urbanization and technological advancements, positions copper as a critical resource for the future, particularly in emerging economies and green technologies.
COP29 Spotlight: Zefiro Methane's Innovative Climate Solutions
Baku, Wednesday, 13 November 2024.
Zefiro Methane Corp’s CCO will address methane emissions at COP29, highlighting the company’s role in sealing abandoned oil wells. With millions of unplugged wells in the U.S. and sealing costs up to $435 billion, Zefiro’s approach offers a significant opportunity for high-quality carbon credits and environmental remediation.
Canada Boosts EV Infrastructure with $9.4 Million Investment
Toronto, Tuesday, 12 November 2024.
Baseload Power Corporation secures $9.4 million from Natural Resources Canada to expand its electric vehicle charging network. The project will add 126 fast chargers by 2025, increasing the company’s network to over 200 stations across Ontario, Quebec, and British Columbia, supporting Canada’s transition to sustainable transportation.
North American ACE Inhibitors Market Set for Robust Growth, Led by Pharma Giants
Dublin, Tuesday, 12 November 2024.
The North American ACE inhibitors market, valued at $2.18 billion in 2023, is projected to reach $2.93 billion by 2029, growing at a CAGR of 5.25%. Pfizer, Novartis, and AstraZeneca lead this expansion, driven by an aging population and rising cardiovascular disease prevalence.